Kimberly Clark Corp vs Vital Farms Inc — how do they compare? Kimberly Clark Corp trades at $97.59 (market cap $32.51B), while Vital Farms Inc trades at $9.33 (market cap $405.27M). The key difference: Kimberly Clark Corp is far larger — about 80.2× Vital Farms Inc's market cap, and Kimberly Clark Corp pays a 5.24% dividend while Vital Farms Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kimberly Clark Corp for 93 Days and Vital Farms Inc for 14 Days on average.
| KMB | VITL | |
|---|---|---|
Market Cap | $32.51B | $405.27M |
Volume | 6,139,913 | 1,810,837 |
Sector | Consumer Staples | Consumer Staples |
52-Week High | $121.44 | $43.40 |
52-Week Low | $93.05 | $8.28 |
Typical Hold Time | 93 Days | 14 Days |
Enterprise Value | $38.07B | $492.28M |
Dividend Yield | 5.24% | — |
Signals from Pluang's Aura AI — not financial advice
Kimberly-Clark (KMB) trades at $97.74, up 1.31% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong profitability with 11.79% net margins and 129.43% ROE, though Q2 2026 earnings missed expectations. Recent news highlights executive transitions and the pending Kenvue acquisition, while dividend sustainability questions emerge amid cash flow pressures. Analyst consensus remains cautious with 61% hold ratings despite a $117.25 price target suggesting 20% upside.
KMB presents a value opportunity with attractive dividend yield near 5%, but faces integration risks from the Kenvue deal and cash flow challenges. The stock's current discount to analyst targets offers potential upside if execution improves, though investors should monitor dividend coverage and acquisition integration closely given the bearish technical trend and mixed earnings performance.
Vital Farms (VITL) trades at $9.435, up 2.11% today, amid a challenging period marked by volatile earnings and negative cash flows. The stock exhibits a bearish technical trend with support near $9 and resistance at $10, while fundamentals show revenue stability but collapsing profitability, with net income margin at 0.02% in 2026. Recent news highlights potential strategic options, including a sale, as the company navigates egg pricing pressure.
The outlook is mixed: analyst consensus is bullish with a $13.11 price target, but near-term risks from industry oversupply and weak margins persist. Upside hinges on execution of strategic reviews and margin recovery, while downside exposure includes sustained cash burn and competitive pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →